Flat Trading Day for Bcal Diagnostics (BDX.AX): Market Overview & Investor Outlook
Flat at AUD 0.08, Bcal Diagnostics trades unchanged amid modest market swings; biotech’s early breast‑cancer test could spark a rebound if new data or approvals surface.
- BCAL DIAGNOSTICS LTD
- Australia
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read